J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Joaquin Duato, CEO of J&J, stated: “Our increased US investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add US-based jobs but manufacture cutting-edge medicines to treat patients in America and around the world.”

The announced additional investments kicked off with the groundbreaking of a new biologics manufacturing facility in Wilson, North Carolina. This facility will expand J&J's capacity to manufacture next-generation medicines for people living with cancer, immune-mediated, and neurological diseases and is expected to create over 500 new positions at the site.

In addition to the new site in Wilson, the J&J’s plans include three new manufacturing facilities and the expansion of several existing sites across the company’s Innovative Medicine and MedTech businesses, as well as “significant” investments in R&D infrastructure and technology.

© Johnson & Johnson
© Johnson & Johnson

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.